Connecticut public health commissioner defends scientific review, warns vaccine confusion is growing

Connecticut Public Health Commissioner Dr. Manisha Juthani said in a broadcast interview that a fellow public health official had faced pressure that conflicted with her ethics and warned that moves to pre-approve vaccines outside established review processes risk undermining public trust.

"Doctor Manares is an experienced scientist. She went through a rigorous confirmation hearing where she was asked a number of questions. And within a month, unfortunately, she was asked to do things that went against her own ethics and what she expects of other public health professionals," Juthani said, arguing that public health recommendations must be grounded in careful evaluation of data.

The commissioner emphasized that science is consistent across clinical care and public health and should not be applied selectively. "At the end of the day, we need to be able to evaluate science and have scientists be the ones to do that," she said, adding that states have been "fully on board with the idea of examining the things that the secretary would like us to look at in public health and do better on." She warned, however, that "pre approving vaccines that would come out of the ACIP meeting that is going to be held over the next 2 days does not give credence to the idea that she as a scientist would evaluate what the other people on the committee evaluated to be able to make those recommendations." (ACIP is the Advisory Committee on Immunization Practices.)

On public confidence, Juthani said confusion persists about who is eligible for vaccines and whether they are safe. "The safety record on vaccines for decades now is something that has been evaluated and investigated both by the FDA and CDC rigorously, administration after administration," she said, and added that states are trying to "ease that confusion, make things more clear for the public." She noted that people have received COVID vaccines for five years and said officials want to reduce barriers for those who want shots.

Juthani also described a common challenge for public health: when prevention works, people stop seeing the harms. "One of the things that is one of the greatest successes of public health is also one of our greatest challenges," she said, citing recent measles outbreaks that she warned could jeopardize the United States' 25-year elimination status if transmission continues.

The interview focused on the public-health implications of leadership changes and messaging; Juthani urged reliance on established scientific review and stepped-up efforts by state health departments to clarify vaccine guidance for the public. There were no formal policy actions or votes discussed during the program.